Wouter J. Plattel

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

Journal: Journal of cancer survivorship : research and practice

Published: April 20, 2026

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up.

Journal: HemaSphere

Published: April 14, 2026

Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.

Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.

Journal: The Lancet. Haematology

Published: December 18, 2025

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology

Published: November 20, 2025

The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.

The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.

Journal: Journal of the National Cancer Institute

Published: November 19, 2025

The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.

The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors.

Journal: Journal of the National Cancer Institute

Published: November 19, 2025

Molecular Profiling and Disease Tracking of Post-transplant Lymphoproliferative Disorders using Cell-free DNA.

Molecular Profiling and Disease Tracking of Post-transplant Lymphoproliferative Disorders using Cell-free DNA.

Journal: Blood advances

Published: October 24, 2025

A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

A phase 1/1b study of the BCMA-targeting bispecific T-cell engager pavurutamab for relapsed/refractory multiple myeloma.

Journal: Blood

Published: October 15, 2025

IMPACT OF RITUXIMAB MAINTENANCE ON SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA; A POPULATION-BASED COHORT STUDY.

IMPACT OF RITUXIMAB MAINTENANCE ON SURVIVAL IN PATIENTS WITH MANTLE CELL LYMPHOMA; A POPULATION-BASED COHORT STUDY.

Journal: Blood advances

Published: October 06, 2025

Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study.

Journal: Blood advances

Published: October 06, 2025

Real-World Outcomes of High Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Multiple Myeloma Older and Younger Than 65 Years.

Real-World Outcomes of High Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Multiple Myeloma Older and Younger Than 65 Years.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 21, 2025

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

Dynamics of circulating tumour DNA in relapsed/refractory diffuse large B-cell lymphoma patients.

Journal: British journal of haematology

Published: September 15, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026